Reata Pharmaceuticals, Inc. carries a market capitalization of 6.57B, placing it among publicly traded companies globally.
| Market Cap | 6.57B |
| Enterprise Value | N/A |
Reata Pharmaceuticals, Inc.'s stock has gained approximately 424.84775% over the past 52 weeks. The 50-day moving average sits at 157.27, while the 200-day moving average is 94.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | 424.84775% |
| 50-Day Moving Average | 157.27 |
| 200-Day Moving Average | 94.36 |
| Average Volume (20 Days) | N/A |